TECFIDERA® Data Confirm Strong and Sustained Efficacy in Newly Diagnosed MS Patients and Real-World Effectiveness

Accessed on 19 Apr 2016 from http://media.biogen.com/press-release/neurodegenerative-diseases/tecfidera-data-confirm-strong-and-sustained-efficacy-newly-.